Abstract: The present invention relates to a novel compound (formula I), which has cancer treatment activity. The present invention also relates to a preparation method for the compound and a pharmaceutical composition containing the compound.

Abstract: A cable management bracket includes a frame and a buckle member. The frame includes a first side portion and a second side portion, wherein the first side portion is opposite to the second side portion. The first side portion has a pivot hole, a first restraining portion and a second restraining portion, wherein the first restraining portion is located between the pivot hole and the second restraining portion. The second side portion has a first engaging portion. The buckle member includes a pivot portion and a second engaging portion. The pivot portion is inserted into the pivot hole and sandwiched in between the first restraining portion and the second restraining portion. The second engaging portion is rotatably engaged with the first engaging portion.

Abstract: A smart door lock assembly includes a lock cylinder, a lock cylinder mounting block, a driving motor, and a driving control board. A driving gear is arranged on a movable end of the driving motor. The lock cylinder passes through and is mounted in the lock cylinder mounting block. A driven gear coaxial with the lock cylinder is arranged on the lock cylinder mounting block. The driven gear is driven by the driving gear. The driving control board determines whether an external input unlocking command is right and controls the driving motor to unlock the smart door lock assembly when the external input unlocking command is right. The driving motor has a virtual position in a process of driving the driving gear.

Abstract: The present invention provides novel methods for treating and preventing colorectal cancer in a subject by administering a composition comprising ?-galactosidase, a bacterial culture capable of producing ?-galactosidase, such as an S. thermophilus culture, or a fraction of the culture comprising ?-galactosidase. A kit useful for such methods is also provided. In addition, the present invention provides a composition for treating or preventing colon cancer.

Abstract: A soft switching sub-circuit forming part of or for use with a circuit. The soft switching sub-circuit comprises a bridge switching circuit. The soft switching sub-circuit is configured and operable to provide a varying current output that tracks output current from the bridge switching circuit to create a substantially zero current through at least one switch component of the bridge switching circuit to enable soft switching.

Abstract: According to examples, an apparatus may include a processor and a memory on which are stored machine-readable instructions that when executed by the processor, may cause the processor to track traffic events and user interface (UI) events in parallel and record a first event of a hybrid test script. The first event may be recorded in a traffic mode to record one or more of the traffic events. The processor may transition from the traffic mode to a UI mode and, responsive to the transition from the traffic mode to the UI mode, may share session data between the traffic events and the UI events. Based on the session data, the processor may record a second event of the hybrid test script in the UI mode.

Abstract: A memory device includes a gate electrode, a gate insulating layer formed on the gate electrode, a tunneling insulating layer stacked on the gate insulating layer, a channel layer stacked on the tunneling insulating layer, and a source electrode and a drain electrode formed on the channel layer to be spaced apart from each other. The tunneling insulating layer suppresses tunneling of charges from any one of the channel layer and the gate electrode by a voltage applied to each of the gate electrode and the drain electrode, and a density of tunneled charges is set according to the voltage applied to the drain electrode to output and store multiple current levels.

Abstract: The present invention provides for compositions and methods for treating colorectal cancer or for reducing the risk of developing the disease in an individual.

Abstract: A method for controlling tobacco bacterial wilt and an application of NaHS in controlling the tobacco bacterial wilt are provided by the present disclosure, and the disclosure belongs to the technical field of plant disease control. By measuring the growth effect of Ralstonia solanacearum in tobacco through plate and shake bottle experiments, the disclosure finds the NaHS has an inhibiting effect on the growth of the pathogen of bacterial wilt; and the influence of different concentration of NaHS on the incidence of bacterial wilt in tobacco is detected, and the result also shows that NaHS has a good effect on resisting bacterial wilt in tobacco. The disclosure finds and proves for the first time that NaHS is an effective antibacterial substance against bacterial wilt and provides a new method for prevention and controlling of the tobacco bacterial wilt.

Abstract: A semiconductor device including a memory device which has improved reliability is provided. The semiconductor device comprises at least one data pin configured to transfer a data signal, at least one command address pin configured to transfer a command and an address, at least one serial pin configured to transfer a serial data signal, and processing circuitry connected to the at least one data pin and the at least one serial pin. The processing circuitry is configured to receive the data signal from outside through the at least one data pin, and the processing circuitry is configured to output the serial data signal through the at least one serial pin in response to the received data signal.

Abstract: The present disclosure relates to a heterocyclic compound being represented by Formula, an organic light emitting device including the heterocyclic compound and an organic light emitting display device including the organic light emitting device. The organic heterocyclic is included in an organic material layer of the organic light emitting device.

Abstract: A semiconductor device includes an active pattern which includes a lower pattern extending in a first direction, and sheet patterns spaced apart from the lower pattern in a second direction perpendicular to an upper surface of the lower pattern, each sheet pattern including an upper surface and a lower surface, a gate structure disposed on the lower pattern and including a gate electrode and a gate insulating film, the gate electrode and the gate insulating film surrounding each sheet pattern, and a source/drain pattern disposed on at least one side of the gate structure. The gate structure includes inter-gate structures that are disposed between the lower pattern and a lowermost sheet pattern and between two sheet patterns, and contacts the source/drain pattern. The gate insulating film includes a horizontal portion with a first thickness, and a first vertical portion with a second thickness different from the first thickness.

Abstract: An automatic robotic arm system and a coordinating method for robotic arm and computer vision thereof are disclosed. A beam-splitting mirror splits an incident light into a visible light and a ranging light and respectively guides to an image capturing device and an optical ranging device arranged in the different reference axes. In a calibration mode, a transformation relation is computed based on a plurality of the calibration postures and corresponding calibration images. In an operation mode, a mechanical space coordinate is determined based on an operation image and the transformation relation, and the robotic arm is controlled to move based on the mechanical space coordinate.

Abstract: Provided is a non-invasive method for diagnosing colorectal cancer in a subject by detecting enrichment or reduction of certain bacterial species. A kit and device useful for such methods are also provided. In addition, a method for reducing the risk of colon cancer by regulating the pertinent bacterial species in human colon is also provided.

Abstract: Disclosed are a polyamide resin composition and a molded article manufactured using the same. The molded article may have excellent mechanical strength, deformation resistance and light resistance, and may be suitable for use without coating. The polyamide resin composition includes a polyamide resin, an auxiliary resin (e.g., an acrylonitrile-butadiene-styrene copolymer), a filler (e.g., glass fibers and glass beads), and a compatibilizer (e.g., copolymer including maleimide).

Abstract: Provided are compounds of formula (I), which have KRAS mutation tumor regulating activity. Also provided are a method for providing these compounds and a pharmaceutical composition comprising the same.

Abstract: The disclosed computer-implemented method may include (i) associating a planar element within a virtual environment with an alternate virtual environment and (ii) rendering the virtual environment such that (A) the alternate virtual environment is framed within the planar element, (B) at least one rendered element of the alternate virtual environment renders at a distal depth beyond a proximal depth of the planar element within the virtual environment, and (C) altering a viewpoint within the virtual environment relative to a position of the planar element within the virtual environment produces a parallax effect between the virtual environment and the rendered element of the alternate virtual environment due at least in part to the rendered element of the alternate virtual environment being rendered at the distal depth beyond the proximal depth of the planar element within the virtual environment. Various other methods, systems, and computer-readable media are also disclosed.

Abstract: The present invention provides novel methods for treating and preventing colorectal cancer in a subject by administering a composition comprising ?-galactosidase, a bacterial culture capable of producing ?-galactosidase, such as an S. thermophilus culture, or a fraction of the culture comprising ?-galactosidase. A kit useful for such methods is also provided. In addition, the present invention provides a composition for treating or preventing colon cancer.

Abstract: The present disclosure generally relates to printed circuit boards or printed circuit board assemblies for fiber optic communications. In one example, an optoelectronic assembly may include a printed circuit board including a laser-roughened area, at least one optoelectronic component coupled to a surface of the printed circuit board, and an optical component attached to the printed circuit board. The coupling area may be defined by the optical component contacting the printed circuit board, and the laser-roughened area may be positioned entirely within the coupling area defined by the optical component contacting the printed circuit board.

Abstract: Detector modules, detectors and medical imaging devices are provided. One of the detector modules includes: a support and a plurality of detector sub-modules arranged on the support along an extension direction in which the support extends. Each of the detector sub-modules has a first area and a second area in the extension direction. A detecting device is disposed in the first area, and a functional module is disposed in the second area. The functional module is electrically connected to the detecting device for receiving an electrical signal from the detecting device. The plurality of detector sub-modules includes a first detector sub-module and a second detector sub-module that are arranged adjacent to each other in the extension direction, and the first area of the first detector sub-module at least partially overlaps with the second area of the second detector sub-module.